| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $10.2M | — |
| SG&A Expense | $2.8M | — |
| Operating Income | -$13.1M | — |
| Pre-tax Income | -$13.1M | — |
| Income Tax | $838 | — |
| Net Income | -$13.1M | — |
| EPS (Basic) | -$0.35 | — |
| EPS (Diluted) | -$0.35 | — |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.4M | +51.0% |
| Current Assets | $1.7M | +2.2% |
| Total Assets | $3.2M | +1.2% |
| Current Liabilities | $13.5M | +351.9% |
| Total Liabilities | $13.5M | +351.9% |
| Stockholders' Equity | -$10.4M | -7312.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.8M | — |
| Financing Cash Flow | $2.3M | — |